Vontobel Holding Ltd. Scholar Rock Holding Corp Transaction History

Vontobel Holding Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jun 03, 2024	BUY	$6.02 - $7.76 $389,271 - $501,784	64,663 Added 26.31%	310,398 $2.2 Million
Q3 2023 Oct 10, 2023	BUY	$6.02 - $7.76 $389,271 - $501,784	64,663 Added 26.31%	310,398 $2.2 Million
Q2 2023 Jun 03, 2024	BUY	$5.79 - $9.11 $643,651 - $1.01 Million	111,166 Added 82.61%	245,735 $1.85 Million
Q2 2023 Jul 24, 2023	BUY	$5.79 - $9.11 $643,651 - $1.01 Million	111,166 Added 82.61%	245,735 $1.85 Million
Q1 2023 Jun 03, 2024	BUY	$7.36 - $12.72 $990,427 - $1.71 Million	134,569 New	134,569 $1.08 Million
Q1 2023 Apr 12, 2023	SELL	$7.36 - $12.72 $122,455 - $211,635	-16,638 Reduced 11.0%	134,569 $1.08 Million
Q4 2022 Feb 14, 2023	BUY	$7.02 - $9.76 $1.06 Million - $1.48 Million	151,207 New	151,207 $1.37 Million

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.